^
BIOMARKER:
TMB-H
i
Other names: TMB | Tumor Mutational Burden
Related biomarkers:
TMB-H
Neuroendocrine Tumor
pembrolizumab
Sensitive
:
A2
NCCN - 3wk
TMB-H
Solid Tumor
pembrolizumab
Sensitive
:
A1
TMB-H
Peritoneal Cancer
pembrolizumab
Sensitive
:
A2
TMB-H
Gastric Cancer
pembrolizumab
Sensitive
:
A2
TMB-H
Testicular Seminoma
TIP
Sensitive
:
A2
TMB-H
Sarcoma
pembrolizumab
Sensitive
:
A2
TMB-H
Thyroid Gland Hurthle Cell Carcinoma
pembrolizumab
Sensitive
:
A2
TMB-H
Chordoma
pembrolizumab
Sensitive
:
A2
TMB-H
Germ Cell Tumors
pembrolizumab
Sensitive
:
A2
TMB-H
Thyroid Gland Follicular Carcinoma
pembrolizumab
Sensitive
:
A2
TMB-H
Thyroid Gland Medullary Carcinoma
pembrolizumab
Sensitive
:
A2
TMB-H
Endometrial Cancer
pembrolizumab
Sensitive
:
A2
TMB-H
Cervical Cancer
pembrolizumab
Sensitive
:
A2
TMB-H
Thyroid Gland Papillary Carcinoma
pembrolizumab
Sensitive
:
A2
TMB-H
NSCLC
nivolumab + ipilimumab
Sensitive
:
A2
TMB-H
Breast Cancer
pembrolizumab
Sensitive
:
A2
TMB-H
Melanoma
nivolumab + ipilimumab
Sensitive
:
A2
TMB-H
Ewing Sarcoma
pembrolizumab
Sensitive
:
A2
TMB-H
Osteosarcoma
pembrolizumab
Sensitive
:
A2
TMB-H
Thyroid Gland Anaplastic Carcinoma
pembrolizumab
Sensitive
:
A2
TMB-H
Gastroesophageal Junction Adenocarcinoma
pembrolizumab
Sensitive
:
A2
TMB-H
Esophageal Cancer
pembrolizumab
Sensitive
:
A2
TMB-H
Ovarian Cancer
pembrolizumab
Sensitive
:
A2
TMB-H
Fallopian Tube Cancer
pembrolizumab
Sensitive
:
A2
TMB-H
NSCLC
atezolizumab
Sensitive
:
B
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our